Status:
COMPLETED
Intravenous Ketorolac for Postoperative Pain in Percutaneous Nephrolithotomy
Lead Sponsor:
Mayo Clinic
Conditions:
Renal Calculus
Kidney Stones
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether continuous intravenous ketorolac infusion reduces pain in patients who are having percutaneous nephrolithotomy for kidney stone disease.
Eligibility Criteria
Inclusion
- Patients undergoing percutaneous nephrolithotomy for kidney stone disease
Exclusion
- History of nonsteroidal antiinflammatory drug allergy
- Asthma
- History of long-term opioid use
- Intraoperative blood loss greater than 300 mL
- Postoperative hemodynamic instability
- Active peptic ulcer disease
- Advanced renal impairment (Creatinine \> 2.0 mg/dL)
- Bleeding diathesis
- Current use of probenecid
- Pregnancy
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT00765128
Start Date
October 1 2008
End Date
November 1 2010
Last Update
January 27 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Phoenix, Arizona, United States, 85054